For a better experience, click the Compatibility Mode icon above to turn off Compatibility Mode, which is only for viewing older websites.

tags

All News tagged "biomedical engineering"

Virginia-Based Start-Up Company Licenses Three Tissue Technologies Developed at Drexel

A trio of tissue engineering technologies developed by researchers and clinicians from Drexel University, the University of Pennsylvania and The Children’s Hospital of Philadelphia are moving one step closer to becoming viable options for vascular surgery, skin replacement and tissue regeneration. Eqalix, Inc., a start-up company from Reston, Va., has recently acquired the exclusive licenses for these three technologies and plans to develop them for commercial use.
President John Fry and ITU President Muhammed Sahin

Drexel President John Fry Leads Delegation to Turkey

Drexel University President John Fry led a delegation of University administrators, faculty from Drexel’s School of Biomedical Engineering, Science and Health Systems and College of Engineering, and representatives from Duke University and The Johns Hopkins University and industry partners through a five-day tour of Turkey’s epicenters for research and technological innovation. This Innovation Partnership Forum Delegation, spent time at some of the nation’s top universities, visited innovative “technoparks” and participated in a national biomedical engineering summit.
Drexel Launches Shima Seiki Haute Technology Laboratory to Develop Smart Textiles and Wearable Technology

Drexel University Finalizes Deal with Shima Seiki USA

Following the signing of a groundbreaking, $1 million agreement with Shima Seiki USA, Genevieve Dion, assistant professor and fashion design program director in Drexel University’s Antoinette Westphal College of Media Arts & Design, will now have the state-of-the-art laboratory to conduct research for the development of new smart textiles, wearable technologies and to explore new methods of production that will ultimately impact a number of market sectors.

President Fry Leads Drexel Delegation to Israel

Drexel University President John A. Fry is leading a delegation to Israel to attend the second Bi-national Symposium on Translational Research in Biomedicine and Biomedical Engineering, jointly sponsored by Hebrew University’s (HUJI) Institute for Drug Research (IDR) and Drexel.
Exterior of the A.J. Drexel Plasma Institute

Drexel Receives Keck Foundation Grant to Expand Plasma Research

Drexel University has received a $1 million grant from the W.M. Keck Foundation to expand research on the fundamental science of interactions between plasma, which is an ionized gas, and living systems. The research, funded by the W.M. Keck Foundation, will be led by the University’s Anthony J. Drexel Plasma Institute.

Joseph Hughes Named Drexel Engineering Dean

Drexel University has named Dr. Joseph B. Hughes, the Karen and John Huff  School chair and professor of civil, environmental and materials science engineering at the Georgia Institute of Technology, as dean of the University’s College of Engineering. Drexel President John A. Fry has announced that Hughes will begin his tenure at Drexel on January 15, 2012.

Onaral receives Israel America Chamber of Commerce Recognition

Drexel University’s Dr. Banu Onaral has been bringing together leaders in technology and industry for years as an H.H. Sun professor and the director of the School of Biomedical Engineering, Science and Health Systems. Her visionary work to further international collaborations for translational research and technology transfer were recognized by the America-Israel Chamber of Commerce on November 15 as the AICC opened its Healthcare Information Technology Conference.

Coulter Foundation Helps Create 20 Million Endowment in Support of Biomedical Innovations

Drexel University was awarded $10 million by the Wallace H. Coulter Foundation to endow the Coulter Translational Research Partnership program. The University matched the Coulter Foundation’s $10 million grant creating a $20 million endowment to bring life saving solutions to clinical practice by moving promising biomedical discoveries to commercialization.